Oracle Corporation
—- Market cap
- —
- Debt
- —
- Cash
- −$31.29B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $279.07B · View financials
Decision snapshot: ORCL stock price vs IBM: inconclusive — current versus $154.60 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IBM's multiple
Implied fair value · at ORCL's multiple
Needs ORCL P/E.
Close Dec 31, 2025
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Oracle Corporation · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
INTERNATIONAL BUSINESS MACHINES CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ORCL can sustain its faster revenue growth and superior profitability versus IBM, then the shares look attractive to own or add because ORCL trades at a lower P/E than IBM and still offers 19.0% implied upside to fair value.
ORCL’s implied price of $154.60 is 19.0% above the current price of $129.87, suggesting the stock is trading below the P/E-based fair value estimate. The current price also sits below the midpoint of the historical band and near the upper half of the DCF range, indicating the market is not fully pricing in ORCL’s stronger operating profile versus IBM.
Supporting Metrics